CapWealth Advisors LLC Reduces Stake in The Clorox Company (NYSE:CLX)

CapWealth Advisors LLC lessened its holdings in shares of The Clorox Company (NYSE:CLX) by 6.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,768 shares of the company’s stock after selling 121 shares during the quarter. CapWealth Advisors LLC’s holdings in Clorox were worth $287,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in CLX. Insight Folios Inc lifted its holdings in Clorox by 3.0% during the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock valued at $358,000 after purchasing an additional 63 shares in the last quarter. HCR Wealth Advisors raised its position in shares of Clorox by 1.0% during the 4th quarter. HCR Wealth Advisors now owns 6,870 shares of the company’s stock valued at $1,116,000 after purchasing an additional 68 shares during the period. Empower Advisory Group LLC lifted its stake in shares of Clorox by 4.5% during the 3rd quarter. Empower Advisory Group LLC now owns 1,823 shares of the company’s stock valued at $297,000 after buying an additional 78 shares in the last quarter. Aviance Capital Partners LLC boosted its holdings in Clorox by 2.7% in the 3rd quarter. Aviance Capital Partners LLC now owns 3,080 shares of the company’s stock worth $502,000 after buying an additional 80 shares during the period. Finally, Lindbrook Capital LLC increased its stake in Clorox by 9.9% in the 3rd quarter. Lindbrook Capital LLC now owns 977 shares of the company’s stock worth $159,000 after buying an additional 88 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Stock Performance

NYSE CLX opened at $147.91 on Friday. The business’s 50 day moving average price is $159.55 and its 200-day moving average price is $159.13. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a market cap of $18.31 billion, a P/E ratio of 40.41, a P/E/G ratio of 2.52 and a beta of 0.42. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.62 and a current ratio of 0.94.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter in the previous year, the business earned $2.16 EPS. Sell-side analysts predict that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th were issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.30%. The ex-dividend date of this dividend was Wednesday, January 29th. Clorox’s dividend payout ratio is currently 133.33%.

Wall Street Analyst Weigh In

CLX has been the topic of several research analyst reports. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research report on Thursday, January 30th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and increased their price objective for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. DA Davidson dropped their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Finally, Barclays lifted their price target on shares of Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $158.21.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.